Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial

Victor F. Tapson, Fernando Torres, Fiona Kermeen, Anne M. Keogh, Roblee P. Allen, Robert P. Frantz, David B. Badesch, Adaani E. Frost, Shelley M. Shapiro, Kevin Laliberte, Jeffrey Sigman, Carl Arneson, Nazzareno Galiè

Research output: Contribution to journalArticlepeer-review

254 Scopus citations

Fingerprint

Dive into the research topics of 'Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences